TIRZE – Tirzepatide 5mg are tested and have required amount of substance of highest quality:
» Test results of our Tirzepatide 5mg
Tirzepatide 5 mg is a high-purity lyophilized research peptide supplied in a sterile glass vial containing 5 mg of active compound per vial. Tirzepatide is a dual incretin receptor agonist targeting GLP-1 and GIP receptors and is widely studied in metabolic and endocrinology research. This product is intended strictly for laboratory and scientific research use only.
Reconstitute:
Add 1.0 mL bacteriostatic water → 10.0 mg for optimal concentration.
Storage after reconstitution:
refrigerate at 2-8 °C and use up to 4 weeks.
What are the benefits of Tirzepatide?
01 Weight management
02 Improved blood sugar control
03 Reduced appetite and food cravings
04 Cardiometabolic support
05 Potential liver health benefits
06 Support for long-term metabolic health
Lyophilized investigational peptide
Tirzepatide 5 mgTirzepatide 5 mg is a premium-grade lyophilized investigational peptide supplied in a sterile sealed glass vial containing 5 milligrams per unit. This compound belongs to a new class of dual incretin receptor agonists designed to activate both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.
Due to its dual-pathway receptor activity, Tirzepatide has gained significant attention in metabolic and endocrinology research. By targeting two complementary incretin pathways, it is being investigated for coordinated metabolic signaling effects in controlled laboratory environments.
This product is strictly intended for research purposes only and is not approved for human or clinical use.
Mechanism of Action
Tirzepatide is engineered to activate:
• GLP-1 receptors
• GIP receptors
The dual-agonist mechanism is being studied for its influence on metabolic signaling pathways and endocrine regulation models. Compared to single GLP-1 receptor agonists, dual receptor activation is under investigation for potential synergistic interactions in research settings.
Research Applications
Tirzepatide 5 mg is commonly used in laboratory research environments focusing on:
• Metabolic regulation models
• Glucose metabolism research
• Hormonal signaling pathway studies
• Energy balance investigations
• Insulin sensitivity analysis
• Obesity-related metabolic pathway research
• Comparative incretin receptor studies
• Dose-response laboratory evaluations
The compound is particularly relevant for research institutions exploring advanced incretin-based peptide mechanisms.
Scientific Context
Dual incretin receptor agonists represent a significant advancement in peptide-based metabolic research. Ongoing preclinical and clinical investigations have increased scientific interest in receptor co-activation strategies and their impact on metabolic pathway modulation.
Tirzepatide is frequently referenced in research examining next-generation incretin signaling compounds and dual receptor activation models.
Product Specifications
Product Name: Tirzepatide
Content: 5 mg per vial
Form: Lyophilized powder
Grade: Research use only
Purity: High laboratory-grade purity
Packaging: Sterile sealed glass vial
Storage: Store refrigerated at 2–8°C
Stability and Handling
The lyophilized format supports stability under appropriate refrigerated storage conditions.
Recommended laboratory handling:
• Store at 2–8°C
• Protect from light and moisture
• Avoid repeated freeze–thaw cycles
• Reconstitute under sterile laboratory conditions
Proper peptide handling helps preserve structural integrity and ensures reliable experimental outcomes.
Research Classification
Tirzepatide is classified as an investigational peptide compound intended exclusively for:
• In vitro laboratory research
• Analytical testing
• Scientific experimentation
• Controlled research applications
This product is not approved for therapeutic, diagnostic, veterinary, or human use.
Important Notice
This product is sold strictly for laboratory research purposes only.
It is not intended for human consumption, medical use, or clinical application. By purchasing this product, the buyer confirms that it will be used solely for lawful scientific research.
Buy risk-free.
GUARANTEEFAQ
FREQUENTLY ASKED QUESTIONSTirzepatide is a dual GIP and GLP-1 receptor agonist. Unlike single-pathway GLP-1 products, tirzepatide activates two incretin pathways, which is why it is considered a distinct option within this category.
TIRZE comes in the form of a lyophilized powder in a glass vial. Before administration, the solution is prepared by adding 1 ml of bacteriostatic water (included in the package).
We accept payment by card, bank transfer, and cash on delivery. We ship via Packeta to Slovakia, the Czech Republic, Poland, Hungary, and Germany. Standard delivery time is up to 10 days. Shipping is free for orders over €100.
We provide customer support by email. We respond within 24 hours. You can contact us at the email address listed in the customer service contact details.
TIRZE acts through dual incretin receptor pathways.
Tirzepatide 5 mgIts activity is mediated by biological signaling mechanisms.
It is designed to engage the dual incretin pathways involved in appetite regulation and metabolic function. Rather than a 1-pathway profile, it reflects focused GIP and GLP-1 receptor activity aligned with the body’s endogenous signaling systems.
